Steven Tepp
Advertisement
Steven TeppPresident & CEOSentinel WorldwideSteve@Sentinelww.com
Articles by Steven Tepp
Deep in the massive bureaucracy of the United Nations is an undertaking that appears to have been conceived and designed to be combative - and biopharma may be the target. Stephen Tepp reports.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
AstraZeneca Taps insitro AI for MASH in Deal Worth Up to $1.5 Billion
2
The Impact That the Renewed Focus on Domestic Manufacturing Might Have on the Supply Chain
3
When Experience, Evidence, and AI Disagree in Pharma, What Should Leaders Do?
4
FDA Launches Rare Disease Framework Initiative
5